| Literature DB >> 33290274 |
Maxime Van Egroo1, Daphne Chylinski1, Justinas Narbutas1,2, Gabriel Besson1, Vincenzo Muto1,2, Christina Schmidt1,2, Davide Marzoli1, Paolo Cardone1, Nora Vandeleene1, Martin Grignard1, André Luxen1, Eric Salmon1,2,3, Christian Lambert4, Christine Bastin1,2, Fabienne Collette1,2, Christophe Phillips1,5, Pierre Maquet1,3, Mohamed Ali Bahri1, Evelyne Balteau1, Gilles Vandewalle1.
Abstract
BACKGROUNDNeuronal hyperexcitability characterizes the early stages of Alzheimer's disease (AD). In animals, early misfolded tau and amyloid-β (Aβ) protein accumulation - both central to AD neuropathology - promote cortical excitability and neuronal network dysfunction. In healthy humans, misfolded tau and Aβ aggregates are first detected, respectively, in the brainstem and frontomedial and temporobasal cortices, decades prior to the onset of AD cognitive symptoms. Whether cortical excitability is related to early brainstem tau - and its associated neuroinflammation - and cortical Aβ aggregations remains unknown.METHODSWe probed frontal cortex excitability, using transcranial magnetic stimulation combined with electroencephalography, in a sample of 64 healthy late-middle-aged individuals (50-69 years; 45 women and 19 men). We assessed whole-brain [18F]THK5351 PET uptake as a proxy measure of tau/neuroinflammation, and we assessed whole-brain Aβ burden with [18F]Flutemetamol or [18F]Florbetapir radiotracers.RESULTSWe found that higher [18F]THK5351 uptake in a brainstem monoaminergic compartment was associated with increased cortical excitability (r = 0.29, P = 0.02). By contrast, [18F]THK5351 PET signal in the hippocampal formation, although strongly correlated with brainstem signal in whole-brain voxel-based quantification analyses (P value corrected for family-wise error [PFWE-corrected] < 0.001), was not significantly associated with cortical excitability (r = 0.14, P = 0.25). Importantly, no significant association was found between early Aβ cortical deposits and cortical excitability (r = -0.20, P = 0.11).CONCLUSIONThese findings reveal potential brain substrates for increased cortical excitability in preclinical AD and may constitute functional in vivo correlates of early brainstem tau accumulation and neuroinflammation in humans.TRIAL REGISTRATIONEudraCT 2016-001436-35.FUNDINGF.R.S.-FNRS Belgium, Wallonie-Bruxelles International, ULiège, Fondation Simone et Pierre Clerdent, European Regional Development Fund.Entities:
Keywords: Aging; Alzheimer’s disease; Neuroimaging; Neuroscience
Mesh:
Substances:
Year: 2021 PMID: 33290274 PMCID: PMC7934880 DOI: 10.1172/jci.insight.142514
Source DB: PubMed Journal: JCI Insight ISSN: 2379-3708